[Federal Register Volume 69, Number 39 (Friday, February 27, 2004)]
[Rules and Regulations]
[Pages 9303-9304]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-4380]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Provisional Patent Application Concerning 2-
Guanidinylimidazolinedione Compounds and Methods of Making and Using 
Thereof

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Provisional Patent 
Application No. 60/523,670 entitled ``2-Guanidinylimidazolinedione 
Compounds and Methods of Making and Using Thereof,'' filed November 21, 
2003. The United States Government, as represented by the Secretary of 
the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The present invention relates to 2-
guanidinylimidazolinedione

[[Page 9304]]

compounds, methods of making and purifying 2-guanidinylimidazolinedione 
compounds, and methods of using the 2-guanidinylimidazolinedione 
compounds to prevent, treat, or inhibit malaria in a subject.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 04-4380 Filed 2-26-04; 8:45 am]
BILLING CODE 3710-08-M